Disclosed positions

Estimated from their latest filings — positions may have changed since

$11.97M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ELVNEnliven Therapeutics, Inc.	235,011	$50.92	$11.97M	100%	2026-02-12

ELVN

Enliven Therapeutics, Inc.

$11.97M

235,011 sh

All filings on record

Every Form 4 transaction we track for this filer

all 15buys 0sells 14

Stock	Transaction	Date	~6mo later
ELVNEnliven Therapeutics, Inc.	Grant — · 20,000 sh	2026-02-12	—
ELVNEnliven Therapeutics, Inc.	Sell $6.9K · 243 sh	2026-01-09	—
ELVNEnliven Therapeutics, Inc.	Sell $1.34M · 48,057 sh	2026-01-09	—
ELVNEnliven Therapeutics, Inc.	Sell $37.1K · 1,705 sh	2025-12-08	—
ELVNEnliven Therapeutics, Inc.	Sell $102.9K · 4,958 sh	2025-12-08	—
ELVNEnliven Therapeutics, Inc.	Sell $11.0K · 613 sh	2025-11-07	—
ELVNEnliven Therapeutics, Inc.	Sell $105.0K · 6,054 sh	2025-11-07	—
ELVNEnliven Therapeutics, Inc.	Sell $134.0K · 6,667 sh	2025-10-07	—
ELVNEnliven Therapeutics, Inc.	Sell $135.0K · 6,667 sh	2025-09-08	—
ELVNEnliven Therapeutics, Inc.	Sell $7.7K · 405 sh	2025-08-07	—
ELVNEnliven Therapeutics, Inc.	Sell $113.9K · 6,262 sh	2025-08-07	—
ELVNEnliven Therapeutics, Inc.	Sell $6.3K · 305 sh	2025-07-07	—
ELVNEnliven Therapeutics, Inc.	Sell $125.6K · 6,362 sh	2025-07-07	—
ELVNEnliven Therapeutics, Inc.	Sell $1.3K · 60 sh	2025-06-09	—
ELVNEnliven Therapeutics, Inc.	Sell $134.3K · 6,607 sh	2025-06-09	—

ELVNGrant

2026-02-12 · Enliven Therapeutics, Inc.

20,000

—

ELVNSell

2026-01-09 · Enliven Therapeutics, Inc.

$6.9K

—

ELVNSell

2026-01-09 · Enliven Therapeutics, Inc.

$1.34M

—

ELVNSell

2025-12-08 · Enliven Therapeutics, Inc.

$37.1K

—

ELVNSell

2025-12-08 · Enliven Therapeutics, Inc.

$102.9K

—

ELVNSell

2025-11-07 · Enliven Therapeutics, Inc.

$11.0K

—

ELVNSell

2025-11-07 · Enliven Therapeutics, Inc.

$105.0K

—

ELVNSell

2025-10-07 · Enliven Therapeutics, Inc.

$134.0K

—

ELVNSell

2025-09-08 · Enliven Therapeutics, Inc.

$135.0K

—

ELVNSell

2025-08-07 · Enliven Therapeutics, Inc.

$7.7K

—

ELVNSell

2025-08-07 · Enliven Therapeutics, Inc.

$113.9K

—

ELVNSell

2025-07-07 · Enliven Therapeutics, Inc.

$6.3K

—

ELVNSell

2025-07-07 · Enliven Therapeutics, Inc.

$125.6K

—

ELVNSell

2025-06-09 · Enliven Therapeutics, Inc.

$1.3K

—

ELVNSell

2025-06-09 · Enliven Therapeutics, Inc.

$134.3K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.